Evidence map›Paper›PMID 36458522›Full record

ArticleNeurogastroenterology and motility2022

5xFAD mice do not have myenteric amyloidosis, dysregulation of neuromuscular transmission or gastrointestinal dysmotility.

Narayana Krishna Yelleswarapu, Marlene Masino, Skye Henderson, Roxanne Fernandes, Greg Swain, James J Galligan, Hui Xu

Open access · hybridAbstract read
In one paragraph

Article in Neurogastroenterology and motility, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The Aging Enteric Nervous System.International journal of molecular sciences · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Narayana Krishna YelleswarapuThe Neuroscience Program, Michigan State University, East Lansing, Michigan, USA.
Marlene MasinoThe Neuroscience Program, Michigan State University, East Lansing, Michigan, USA.
Skye HendersonDepartment of Chemistry, Michigan State University, East Lansing, Michigan, USA.
Roxanne FernandesDepartment of Pharmacology & Toxicology, Michigan State University, East Lansing, Michigan, USA.
Greg SwainThe Neuroscience Program, Michigan State University, East Lansing, Michigan, USA.
James J GalliganThe Neuroscience Program, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0001-7882-5596
Hui XuThe Neuroscience Program, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0003-0934-6916
Michigan State University · US

Funding

Integrative Pharmacological Sciences Training Program (IPSTP)T32GM142521 · NIGMS · MICHIGAN STATE UNIVERSITY · PI ANNE M. DORRANCE, Gina Marie Leinninger · 2021 to 2026
$2.4M
Identification of enteric nerve circuits controlling gut motilityR01DK121272 · NIDDK · MICHIGAN STATE UNIVERSITY · PI GALLIGAN, JAMES J. · 2019 to 2023
$2.1M
NIDDK NIH HHS R01 DK121272NIGMS NIH HHS T32 GM142521
6 · The paper itself

Abstract

backgroundAlterations in gastrointestinal (GI) function and the gut-brain axis are associated with progression and pathology of Alzheimer's Disease (AD). Studies in AD animal models show that changes in the gut microbiome and inflammatory markers can contribute to AD development in the central nervous system (CNS). Amyloid-beta (Aβ) accumulation is a major AD pathology causing synaptic dysfunction and neuronal death. Current knowledge of the pathophysiology of AD in enteric neurons is limited, and whether Aβ accumulation directly disrupts enteric neuron function is unknown.

methodsIn 6-month-old 5xFAD (transgenic AD) and wildtype (WT) male and female mice, GI function was assessed by colonic transit in vivo; propulsive motility and GI smooth muscle contractions ex vivo; electrochemical detection of enteric nitric oxide release in vitro, and changes in myenteric neuromuscular transmission using smooth muscle intracellular recordings. Expression of Aβ in the brain and colonic myenteric plexus in these mice was determined by immunohistochemistry staining and ELISA assay. KEY

resultsAt 6 months, 5xFAD mice did not show significant changes in GI motility or synaptic neurotransmission in the small intestine or colon. 5xFAD mice, but not WT mice, showed abundant Aβ accumulation in the brain. Aβ accumulation was undetectable in the colonic myenteric plexus of 5xFAD mice.

conclusions5xFAD AD mice are not a robust model to study amyloidosis in the gut as these mice do not mimic myenteric neuronal dysfunction in AD patients with GI dysmotility. An AD animal model with enteric amyloidosis is required for further study.

Indexed as

AmyloidosisAnimalsDisease Models, AnimalFemaleMaleMiceMyenteric PlexusNeuronsSubmucous PlexusSynaptic Transmissionamyloid-βenteric neurotransmissiongastrointestinal motilitytransgenic AD mice

Identifiers

PMID36458522
PMCPMC9718934
OpenAlexW4289886022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.